← Sites
701 (USA)
USA
PI: Dr. Reyes
activated
KRI 0.1
Patients
51
Active (enrolled/consented)
0
Withdrawn
3
Serious AEs
0
Open QA findings
1
Aged data queries
0
Studies & contracts total budget 529500.00 USD
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
study completed
contract executed
529500 USD
Patients first 51
| Ref | Status | Consented | Study |
|---|---|---|---|
| 701-1015 | completed | 2014-01-02 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1023 | completed | 2012-08-05 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1028 | completed | 2013-07-19 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1033 | completed | 2014-03-18 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1034 | completed | 2014-07-01 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1047 | completed | 2013-02-12 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1057 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 701-1097 | completed | 2014-01-01 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1111 | completed | 2012-09-07 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1115 | completed | 2012-11-30 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1118 | completed | 2014-03-12 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1130 | completed | 2014-02-15 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1133 | completed | 2012-10-28 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1145 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 701-1146 | completed | 2013-05-20 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1148 | completed | 2013-08-23 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1153 | completed | 2013-09-23 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1162 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 701-1176 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 701-1180 | completed | 2013-02-12 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1181 | completed | 2013-12-05 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1188 | completed | 2013-02-15 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1192 | completed | 2012-07-22 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1203 | completed | 2013-02-02 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1211 | completed | 2012-11-15 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1234 | completed | 2013-03-30 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1239 | completed | 2014-01-11 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1240 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 701-1275 | withdrawn | 2014-02-07 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1287 | completed | 2014-01-25 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1294 | completed | 2013-03-24 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1302 | completed | 2013-08-29 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1307 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 701-1317 | completed | 2014-05-22 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1324 | completed | 2012-10-02 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1341 | completed | 2013-01-05 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1345 | completed | 2013-10-08 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1356 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 701-1360 | withdrawn | 2013-07-31 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1363 | completed | 2013-05-30 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1369 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 701-1383 | completed | 2013-02-04 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1386 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 701-1387 | completed | 2014-03-12 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1392 | completed | 2012-10-28 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1411 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 701-1415 | completed | 2013-09-23 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1429 | withdrawn | 2013-03-19 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1440 | completed | 2013-08-08 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1442 | completed | 2013-10-26 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 701-1444 | completed | 2013-01-05 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
Luna participants (0)
No participants at this site use Luna yet.
Safety 238 AEs · 0 serious
No serious adverse events at this site.
QA findings 1 open
open
major
Protocol deviation
PROTOCOL VIOLATION: PROTOCOL VIOLATION (subject 701-1387, 2014-03-25)
Monitoring visits (0)
No visits recorded.
Payments (0)
No payments on file.